Modeling Accurately Predicts Efficacious Islatravir QW Dose with no Lymphocyte and CD4 Changes
CROI 2025 SF March 9-12
Diane Longo1, Michelle Pham1, Marjorie Imperial2, Gillian Gillespie1, Stephanie Klopfer1, Randolph P. Matthews1, Cyril Llamoso1, Elizabeth G. Rhee1, Martin Rhee2, Dhananjay Marathe2, Ryan Vargo1 1Merck & Co., Inc., Rahway, NJ, USA 2Gilead Sciences, Foster City, CA, USA
